The purpose of this study is to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan.
A longitudinal study will be conducted to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan. A cohort of schoolchildren (6-15 years of age) was investigated before and 1 year after treatment with a single dose of praziquantel 40mg/kg.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
520
praziquantel 40 mg/kg oral tablets
Al Salamania
Al Salamania, River Nile, Sudan
cure rate
The reduction of the prevalence and intensity of S.haematobium infection following a single dose of praziquantel40mg/kg
Time frame: one year
reduction in the intensity of infection by
will a single dose of PZQ significantly reduced intensity of infection of S. haematobium infection 1 year after treatment
Time frame: one year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.